MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/jitc-2025-011768

Медицинская библиотека · Journal for immunotherapy of cancer · 2025

Acquisition of an immunosuppressive microenvironment after anti-CD19 CAR T-cell therapy is associated with T-cell dysfunction and resistance.

Ponzo Marianna, Drufuca Lorenzo, Buracchi Chiara, Sindoni Marco M, Nucera Silvia, Bugarin Cristina, Bason Ramona, Rossetti Grazisa, Bonnal Raoul, Meli Cristian, Rambaldi Benedetta, Lussana Federico, Ferrari Silvia, Moretti Alex, Dastoli Giuseppe, Risca Giulia, Pellegrino Christian, Manz Markus G, Galimberti Stefania, Rambaldi Alessandro, Gaipa Giuseppe, Biondi Andrea, Pagani Massimiliano, Magnani Chiara F

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Chimeric antigen receptor (CAR) T cells targeting CD19 induce durable responses in B-cell acute lymphoblastic leukemia (B-ALL). However, the contribution of the tumor microenvironment to the therapeutic response after CAR T-cell treatment remains incompletely understood.

METHODS

We performed single-cell RNA sequencing and spectral flow cytometry-based analyses of bone marrow-resident immune cells from B-ALL patients before and after CAR T-cell treatment.

RESULTS

We observed profound changes in the microenvironment in response to CAR T-cell-mediated inflammation, including an increase in myeloid cells. Significant induction of the interferon response, hypoxia, and TGF-β signaling was accompanied by expansion of myeloid-derived suppressor cells (MDSCs) and endogenous exhausted CD8+ T cells. PD-1 expression in endogenous T cells post-treatment was associated with a lack of durable response in the cohort of patients analyzed. Further, we revealed that HIF-1α, VEGF, and TGFBR2 are key players in the intercellular communication between CAR T cells and the immune niche, potentially driving widespread T-cell dysfunction. Infusion of anti-CD19 CAR T cells led to increased accumulation of human MDSCs, exacerbation of a hypoxic environment and T-cell exhaustion in hematopoietic stem/progenitor cell-humanized mice bearing a human tumor.

CONCLUSIONS

In conclusion, CAR T-cell-mediated myeloid activation is associated with pathways of immune dysregulation that may antagonize the effects of therapy.

Для цитирования: Ponzo Marianna, Drufuca Lorenzo, Buracchi Chiara, Sindoni Marco M, Nucera Silvia, Bugarin Cristina, Bason Ramona, Rossetti Grazisa, Bonnal Raoul, Meli Cristian, Rambaldi Benedetta, Lussana Federico, Ferrari Silvia, Moretti Alex, Dastoli Giuseppe, Risca Giulia, Pellegrino Christian, Manz Markus G, Galimberti Stefania, Rambaldi Alessandro, Gaipa Giuseppe, Biondi Andrea, Pagani Massimiliano, Magnani Chiara F. Acquisition of an immunosuppressive microenvironment after anti-CD19 CAR T-cell therapy is associated with T-cell dysfunction and resistance.. Journal for immunotherapy of cancer. 2025. DOI: 10.1136/jitc-2025-011768.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.